Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

15.45

-0.40 (-2.52%)

At close: Aug 10, 2026, 4:00 PM EDT

15.50

+0.05 (0.32%)

After-hours: Aug 10, 2026, 6:35 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	286.86	283.06	235.13	175.51	134.03	45.61
Revenue Growth	18.75%	20.38%	33.97%	30.95%	193.89%	-9.01%
Cost of Revenue	28.09	32.67	28.25	14.15	5.66	1.09
Gross Profit	258.77	250.39	206.89	161.37	128.37	44.51
Selling, General & Admin	94.01	101.79	172.03	195.04	196.37	173.54
Research & Development	35.99	32.51	20.79	49.64	44.99	51.14
Other Operating Expenses	-8.25	11.18	18.76	8.38	-1.52	0.57
Total Operating Expenses	121.74	145.48	211.57	253.06	239.84	225.25
Operating Income	137.02	104.91	-4.69	-91.69	-111.47	-180.74
Interest Income	12.72	13.57	16.97	17	5.12	0.53
Interest Expense	-3.83	-4.33	-4.84	-2.78	-	-
Total Non-Operating Income (Expense)	8.89	9.24	12.14	14.22	5.12	0.53
Pretax Income	145.91	114.16	7.45	-77.47	-106.35	-180.21
Provision for Income Taxes	-157.12	-173.05	1.7	0.55	1.83	0.76
Net Income	303.03	287.2	5.75	-78.02	-108.18	-180.97
Net Income to Common	303.03	287.2	5.75	-78.02	-108.18	-180.97
Net Income Growth	451.63%	4893.08%	-	-	-	-
Shares Outstanding (Basic)	132	134	143	143	142	129
Shares Outstanding (Diluted)	137	139	146	143	142	129
Shares Change	-5.65%	-5.13%	2.07%	0.93%	9.70%	9.20%
EPS (Basic)	2.39	2.14	0.04	-0.54	-0.76	-1.40
EPS (Diluted)	2.29	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	432.56%	5075.00%	-	-	-	-
Free Cash Flow	149.87	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	62.14%	206.99%	-	-	-	-
Free Cash Flow Per Share	1.10	0.98	0.30	-0.24	-0.56	-1.22
Gross Margin	90.21%	88.46%	87.99%	91.94%	95.77%	97.61%
Operating Margin	47.77%	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Profit Margin	105.64%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
FCF Margin	52.24%	47.84%	18.76%	-19.47%	-59.55%	-346.44%
EBITDA	153.54	124.36	14.76	-80.04	-108.76	-177.97
EBITDA Margin	53.53%	43.94%	6.28%	-45.61%	-81.15%	-390.25%
EBIT	137.02	104.91	-4.69	-91.69	-111.47	-180.74
EBIT Margin	47.77%	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Effective Tax Rate	-107.68%	-151.58%	22.77%	-0.71%	-1.72%	-0.42%

SEC Filings: 10-K · 10-Q